| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.1 | 0.6 |